G. V. Shivashankar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
G. V. Shivashankar has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Uhler
Massachusetts Institute of Technology, USA
17 shared publications Luezhen Yuan
Broad Institute of Massachusetts Institute of Technology and Harvard
9 shared publications- Doorgesh Sharma Jokhun
Mechanobiology Institute and Department of Biological Sciences, National University of Singapore, 117411, Singapore
8 shared publications Rajshikhar Gupta
Paul Scherrer Institut
8 shared publicationsYejun Wang
Mechanobiology Institute, National University of Singapore, 117411 Singapore
7 shared publications- Abhishek Kumar
Yale Cardiovascular Research Center, Department of Internal Medicine (Division of Cardiovascular Medicine)
5 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0361202
Coupling between adhesome assembly and 3D chromatin organization
Proteins on the cell membrane cluster to respond to extracellular signals; for example, adhesion proteins cluster to enhance extracellular matrix sensing. The maturation of such receptor clusters may require additional adhesome proteins to adapt and reinforce extracellular signal sensing. However, it has been unclear whether the genes encoding these proteins share a spatial organization in the nucleus. Using the adhesome as an example, we show that subsets of genes that code for adhesome proteins exhibit relative spatial clustering and co-regulation in distinct locations within the nucleus. We use Hi-C maps and RNA-seq data from adherent cells to map the correspondence between adhesome gene localization and their expression. Interestingly, we find that the genes encoding several transcription factors, cofactors, and chromatin regulators that regulate these genes are also co-localized with the adhesome gene loci, thereby potentially suggesting a link between the extracellular matrix sensing machinery and gene expression. Additionally, we validate the spatial sub-clustering of adhesome gene loci using MERFISH data and DNA-FISH experiments. Collectively, our results support an association between adhesome gene organization and regulatory state, with a possible role in cellular signal sensing.
- 29 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0361202
Open AccessCoupling between adhesome assembly and 3D chromatin organization
Proteins on the cell membrane cluster to respond to extracellular signals; for example, adhesion proteins cluster to enhance extracellular matrix sensing. The maturation of such receptor clusters may require additional adhesome proteins to adapt and reinforce extracellular signal sensing. However, it has been unclear whether the genes encoding these proteins share a spatial organization in the nucleus. Using the adhesome as an example, we show that subsets of genes that code for adhesome proteins exhibit relative spatial clustering and co-regulation in distinct locations within the nucleus. We use Hi-C maps and RNA-seq data from adherent cells to map the correspondence between adhesome gene localization and their expression. Interestingly, we find that the genes encoding several transcription factors, cofactors, and chromatin regulators that regulate these genes are also co-localized with the adhesome gene loci, thereby potentially suggesting a link between the extracellular matrix sensing machinery and gene expression. Additionally, we validate the spatial sub-clustering of adhesome gene loci using MERFISH data and DNA-FISH experiments. Collectively, our results support an association between adhesome gene organization and regulatory state, with a possible role in cellular signal sensing.
- Open Access
- 13 October 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Deep learning-based analysis reveals patient-level cancer therapy trajectories using single-cell PBMC chromatin images
Peripheral blood mononuclear cells (PBMCs) profiled in different data modalities have emerged as diagnostic and prognostic biomarkers for cancer. Here we demonstrate that PBMC chromatin images contain sufficient information to track patients’ trajectories during and after radiation therapy. We collected images from 150 patients across a variety of cancer types including Central Nervous System (CNS) cancer, Head & Neck cancer, Chordoma and Chondrosarcoma, Sarcoma, and Lymphoma, and adapted a multiple instance learning-based framework, which effectively enhanced the patient-level classification and interpretation of images from diverse samples compared to simpler cell-level neural network-based classifiers. We found that patients whose PBMCs returned to a state more similar to healthy after the therapy had more favorable outcomes. Moreover, our framework could indicate whether Head & Neck cancer patients’ PBMCs would likely return to a state similar to healthy after radiation therapy using solely chromatin images from before the treatment. These findings motivate further study of PBMC chromatin images to be used as a non-invasive, easily obtained, and inexpensive biomarker for cancer detection, treatment monitoring, and treatment response prediction.
- 13 October 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessDeep learning-based analysis reveals patient-level cancer therapy trajectories using single-cell PBMC chromatin images
Peripheral blood mononuclear cells (PBMCs) profiled in different data modalities have emerged as diagnostic and prognostic biomarkers for cancer. Here we demonstrate that PBMC chromatin images contain sufficient information to track patients’ trajectories during and after radiation therapy. We collected images from 150 patients across a variety of cancer types including Central Nervous System (CNS) cancer, Head & Neck cancer, Chordoma and Chondrosarcoma, Sarcoma, and Lymphoma, and adapted a multiple instance learning-based framework, which effectively enhanced the patient-level classification and interpretation of images from diverse samples compared to simpler cell-level neural network-based classifiers. We found that patients whose PBMCs returned to a state more similar to healthy after the therapy had more favorable outcomes. Moreover, our framework could indicate whether Head & Neck cancer patients’ PBMCs would likely return to a state similar to healthy after radiation therapy using solely chromatin images from before the treatment. These findings motivate further study of PBMC chromatin images to be used as a non-invasive, easily obtained, and inexpensive biomarker for cancer detection, treatment monitoring, and treatment response prediction.
- Open Access
- 29 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Chromatin biomarkers reveal the fingerprints of cancer-associated secretomes isolated by a micropillar-guided platform
Current liquid-biopsy technologies predominantly rely on genomic and proteomic analyses to detect tumor-derived signals in blood. However, the extremely low abundance of tumor secretome components remains a major limitation for reliable detection. Here, we introduce an AI-driven imaging framework that leverages chromatin-based cellular fingerprints as functional biosensors to detect cancer-associated blood-derived secretome signals. As a proof of concept, we demonstrate that human stromal fibroblasts exhibit a higher signal-to-noise ratio for detecting prostate cancer-derived secretomes isolated from whole blood compared with immune cells. Notably, aged fibroblasts display enhanced sensitivity relative to their young counterparts and T cells. To achieve a fully integrated sample-to-sensing workflow, we combined this imaging approach with a micropillar-guided secretome/plasma isolation platform coupled to an on-chip cell-culture chamber, enabling rapid exposure of sensor cells to tumor-derived secretome factors. Together, our results establish a proof-of-concept exploratory study demonstrating the feasibility of chromatin-based functional biosensing of cancer-associated blood-derived secretome signals.
- 29 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessChromatin biomarkers reveal the fingerprints of cancer-associated secretomes isolated by a micropillar-guided platform
Current liquid-biopsy technologies predominantly rely on genomic and proteomic analyses to detect tumor-derived signals in blood. However, the extremely low abundance of tumor secretome components remains a major limitation for reliable detection. Here, we introduce an AI-driven imaging framework that leverages chromatin-based cellular fingerprints as functional biosensors to detect cancer-associated blood-derived secretome signals. As a proof of concept, we demonstrate that human stromal fibroblasts exhibit a higher signal-to-noise ratio for detecting prostate cancer-derived secretomes isolated from whole blood compared with immune cells. Notably, aged fibroblasts display enhanced sensitivity relative to their young counterparts and T cells. To achieve a fully integrated sample-to-sensing workflow, we combined this imaging approach with a micropillar-guided secretome/plasma isolation platform coupled to an on-chip cell-culture chamber, enabling rapid exposure of sensor cells to tumor-derived secretome factors. Together, our results establish a proof-of-concept exploratory study demonstrating the feasibility of chromatin-based functional biosensing of cancer-associated blood-derived secretome signals.
- Open Access
- 26 March 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (13)
Chromatin accessibility regulates age-dependent nuclear mechanotransduction
The integration of environmental cues into cellular programs is crucial for cell function. Yet, how this integration is modulated due to cellular aging remains unclear. We propose that the 3D chromatin organization filters these signals and investigated how age-related chromatin changes in human dermal fibroblasts affect responses to mechanical tension and TGF-β. Young fibroblasts exhibited synergistic gene expression enhancement in response to combined stimuli, a response that was markedly blunted or divergent in aged cells. These distinct outcomes correlated with significant age-related differences in chromatin accessibility. We identified the AP-1 complex and other transcription factors with age-specific activity as pivotal in remodeling chromatin and orchestrating these divergent mechanochemical responses during cellular aging. We validated that disrupting AP-1 activity inhibits fibroblast activation by preventing JUNB recruitment to the transcription machinery. Our findings establish chromatin as a key integrator of mechanochemical signals and characterize the age-related alterations to this integration that modify the cellular responsiveness of aged cells, highlighting AP-1 and its network as potential therapeutic targets against age-related decline.
- 26 March 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (13)
Open AccessChromatin accessibility regulates age-dependent nuclear mechanotransduction
The integration of environmental cues into cellular programs is crucial for cell function. Yet, how this integration is modulated due to cellular aging remains unclear. We propose that the 3D chromatin organization filters these signals and investigated how age-related chromatin changes in human dermal fibroblasts affect responses to mechanical tension and TGF-β. Young fibroblasts exhibited synergistic gene expression enhancement in response to combined stimuli, a response that was markedly blunted or divergent in aged cells. These distinct outcomes correlated with significant age-related differences in chromatin accessibility. We identified the AP-1 complex and other transcription factors with age-specific activity as pivotal in remodeling chromatin and orchestrating these divergent mechanochemical responses during cellular aging. We validated that disrupting AP-1 activity inhibits fibroblast activation by preventing JUNB recruitment to the transcription machinery. Our findings establish chromatin as a key integrator of mechanochemical signals and characterize the age-related alterations to this integration that modify the cellular responsiveness of aged cells, highlighting AP-1 and its network as potential therapeutic targets against age-related decline.
- Open Access
- 17 March 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Detecting chromatin state alterations in PBMCs associated with Type 2 Diabetes Mellitus
Background: Type 2 Diabetes Mellitus (T2DM) involves patient-specific immune dysfunction not addressed by current diabetes management methods. Traditional methods to assess functional changes to PBMCs are too costly and time-intensive for routine use. Methods: We studied 57 individuals across healthy, prediabetic, and diabetic stages, performing chromatin imaging of live peripheral blood mononuclear cells (PBMCs) using a microfluidic imaging assay. Results: Here, we present an orthogonal and adjunct chromatin imaging-based assay to monitor alterations to PBMCs during T2DM progression. By applying representation learning on chromatin images, we identified distinct PBMC clusters, with specific subpopulations enriched at different T2DM stages. We found that the levels of certain PBMC subsets are predictive of T2DM. Additionally, we observed significant changes in nuclear and chromatin mechanics in diabetic individuals compared to prediabetic and healthy individuals, along with decreased Lamin A/C expression and increased cellular activation in diabetic PBMCs. Conclusions: Collectively, this study demonstrated a cost-effective and scalable solution for the routine monitoring of T2DM using PBMC chromatin biomarkers.
- 17 March 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Open AccessDetecting chromatin state alterations in PBMCs associated with Type 2 Diabetes Mellitus
Background: Type 2 Diabetes Mellitus (T2DM) involves patient-specific immune dysfunction not addressed by current diabetes management methods. Traditional methods to assess functional changes to PBMCs are too costly and time-intensive for routine use. Methods: We studied 57 individuals across healthy, prediabetic, and diabetic stages, performing chromatin imaging of live peripheral blood mononuclear cells (PBMCs) using a microfluidic imaging assay. Results: Here, we present an orthogonal and adjunct chromatin imaging-based assay to monitor alterations to PBMCs during T2DM progression. By applying representation learning on chromatin images, we identified distinct PBMC clusters, with specific subpopulations enriched at different T2DM stages. We found that the levels of certain PBMC subsets are predictive of T2DM. Additionally, we observed significant changes in nuclear and chromatin mechanics in diabetic individuals compared to prediabetic and healthy individuals, along with decreased Lamin A/C expression and increased cellular activation in diabetic PBMCs. Conclusions: Collectively, this study demonstrated a cost-effective and scalable solution for the routine monitoring of T2DM using PBMC chromatin biomarkers.
- Open Access
- 25 February 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (3) , 285-300
Partially shared multi-modal embedding learns holistic representation of cell state
Current technologies enable the simultaneous measurement of diverse data types at the single-cell level. However, data are often processed separately, or integrated via representation learning methods that obscure the contributions of each data modality. Here we present a computational framework that automatically learns partial information sharing between multiple modalities by using an Autoencoder with a Partially Overlapping Latent space learned through Latent Optimization (APOLLO). We tested APOLLO on simulated data, and on four applications involving paired single-cell data: SHARE-seq (scRNA-seq and scATAC-seq), CITE-seq (scRNA-seq and protein abundance), and two multiplexed imaging datasets. APOLLO enables the prediction of missing modalities, such as unmeasured protein stains, and allows disentangling which modality or cellular compartment is linked with a specific phenotype, such as the variability in protein localization observed across single cells. Overall, APOLLO efficiently integrates diverse data modalities and, by retaining and distinguishing between shared and modality-specific information, provides a more interpretable and holistic view of cell state.
- 25 February 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (3) , 285-300
Open AccessPartially shared multi-modal embedding learns holistic representation of cell state
Current technologies enable the simultaneous measurement of diverse data types at the single-cell level. However, data are often processed separately, or integrated via representation learning methods that obscure the contributions of each data modality. Here we present a computational framework that automatically learns partial information sharing between multiple modalities by using an Autoencoder with a Partially Overlapping Latent space learned through Latent Optimization (APOLLO). We tested APOLLO on simulated data, and on four applications involving paired single-cell data: SHARE-seq (scRNA-seq and scATAC-seq), CITE-seq (scRNA-seq and protein abundance), and two multiplexed imaging datasets. APOLLO enables the prediction of missing modalities, such as unmeasured protein stains, and allows disentangling which modality or cellular compartment is linked with a specific phenotype, such as the variability in protein localization observed across single cells. Overall, APOLLO efficiently integrates diverse data modalities and, by retaining and distinguishing between shared and modality-specific information, provides a more interpretable and holistic view of cell state.
- 6 February 2026
- Published by EMBL-EBI
Detecting chromatin state alterations in PBMCs associated with Type 2 Diabetes Mellitus
- 6 February 2026
- Published by EMBL-EBI
Detecting chromatin state alterations in PBMCs associated with Type 2 Diabetes Mellitus
- Open Access
- 26 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 42119
Identifying regulators of aged fibroblast activation in 3D tissue models
Robust 3D tissue culture models to activate aged fibroblasts for cell-based therapies and identify regulators of such activation are still missing. In our previous study, we showed that aged fibroblasts can be activated simply through applying compressive force, without the need for exogenous factors, leading to increased migration. In this study, we develop a pipeline to evaluate the role of specific pharmacological inhibitors for transcription factor inference and cell migration involved in aged fibroblast activation. By integrating RNA-seq data with bioinformatic tools (prize collecting Steiner tree method and iRegulon) we inferred 15 candidates. In addition, we used cell migration and heterochromatin content as readouts for validating these candidates. Furthermore, we identified three potential master regulators of fibroblast activation and rejuvenation: FOXO1, STAT3, and PDK1. These findings offer valuable insights for future drug discovery, disease modeling, and regenerative medicine.
- 26 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 42119
Open AccessIdentifying regulators of aged fibroblast activation in 3D tissue models
Robust 3D tissue culture models to activate aged fibroblasts for cell-based therapies and identify regulators of such activation are still missing. In our previous study, we showed that aged fibroblasts can be activated simply through applying compressive force, without the need for exogenous factors, leading to increased migration. In this study, we develop a pipeline to evaluate the role of specific pharmacological inhibitors for transcription factor inference and cell migration involved in aged fibroblast activation. By integrating RNA-seq data with bioinformatic tools (prize collecting Steiner tree method and iRegulon) we inferred 15 candidates. In addition, we used cell migration and heterochromatin content as readouts for validating these candidates. Furthermore, we identified three potential master regulators of fibroblast activation and rejuvenation: FOXO1, STAT3, and PDK1. These findings offer valuable insights for future drug discovery, disease modeling, and regenerative medicine.
- 12 May 2025
- Published by Elsevier in Cell Systems
- Vol. 16 (6) , 101293
Image2Reg: Linking chromatin images to gene regulation using genetic and chemical perturbation screens
- 12 May 2025
- Published by Elsevier in Cell Systems
- Vol. 16 (6) , 101293
Image2Reg: Linking chromatin images to gene regulation using genetic and chemical perturbation screens
- Open Access
- 24 April 2025
- Published by Springer Nature in npj Precision Oncology
- Vol. 9 (1) , 1
Author Correction: Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies
- 24 April 2025
- Published by Springer Nature in npj Precision Oncology
- Vol. 9 (1) , 1
Open AccessAuthor Correction: Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies